Financhill
Back

Revance Therapeutics Quote, Financials, Valuation and Earnings

Revance Therapeutics Price Quote

$3.09
+0.01 (+0.65%)
(Updated: December 21, 2024 at 5:45 AM ET)

Revance Therapeutics Key Stats

Sell
13
Revance Therapeutics (RVNC) is a Sell

Day range:
$3.07 - $3.09
52-week range:
$2.30 - $9.75
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.16
P/B ratio:
0%

Volume:
3.5M
Avg. volume:
3.6M
1-year change:
-59.37%
Market cap:
$323.1M
Revenue:
$234M
EPS:
$-1.94

How Much Does Revance Therapeutics Make?

Data Unavailable

Is Revance Therapeutics Growing As A Company?

Data Unavailable

Revance Therapeutics Stock Price Performance

What Is Revance Therapeutics 52-Week High & Low?

Revance Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Revance Therapeutics?

Data Unavailable

Is Revance Therapeutics Cash Flow Positive?

Data Unavailable

Revance Therapeutics Return On Invested Capital

Data Unavailable

Revance Therapeutics Earnings Date & Stock Price

Revance Therapeutics Competitors

  • Who Are Revance Therapeutics's Competitors?
    Below is a list of companies who compete with Revance Therapeutics or are related in some way:
    • Cellectar Biosciences Inc (CLRB)
    • Ligand Pharmaceuticals Inc (LGND)
    • MEI Pharma Inc (MEIP)
    • Regeneron Pharmaceuticals Inc (REGN)
    • Recursion Pharmaceuticals Inc (RXRX)

Revance Therapeutics Dividend Yield

Data Unavailable

Revance Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 6.33%
Revenue: 10.66% -12.17%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 7
Sell Recommendations: 0
Price Target: 7.64
Upside from Last Price: 147.96%

Major Shareholders

Data Unavailable